PRIMARY VITREORETINAL LYMPHOMA

Clinical trials for PRIMARY VITREORETINAL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PRIMARY VITREORETINAL LYMPHOMA trials appear

Sign up with your email to follow new studies for PRIMARY VITREORETINAL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New eye injection trial targets rare lymphoma

Disease control Recruiting now

This study is testing an experimental injection (ADX-2191) directly into the eye to treat primary vitreoretinal lymphoma, a rare cancer. It will compare two different dosing schedules to see which is safer and more effective at clearing cancer cells. The trial is recruiting about…

Matched conditions: PRIMARY VITREORETINAL LYMPHOMA

Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

PRIMARY VITREORETINAL LYMPHOMA

Get alerted when new PRIMARY VITREORETINAL LYMPHOMA trials appear

New eye injection trial targets rare lymphoma